Jacqui McCallum: Stroke Foundation Brings Stroke Advocacy to State Parliaments
Jacqui McCallum, Executive Director, Brand, Communications and Advocacy at the Stroke Foundation, reposted from Stroke Foundation on LinkedIn:
”Big week for the Stroke Foundation advocacy A-team with Parliamentary events in New South Wales and Victoria.
A huge thank you to our lived experience representatives who continue to share their stories with courage and generosity, and to the MPs who attended and committed their support.
As you can see, Lisa‘s hands are ready for a big novelty cheque.
While Victoria has made significant progress in stroke treatment, we need greater investment in stroke awareness and recovery.
Funding to increase F.A.S.T. awareness will help more Australians recognise the signs of stroke and act quickly, while investment in rehabilitation and recovery services will help survivors rebuild their lives and achieve the best possible outcomes.”
Quoting Stroke Foundation‘s post:
”Celebrating 30 years of impact with Stroke Foundation today at Parliament of Victoria.
It was incredible to see so many dedicated members of our community come together.
The fight against stroke takes all of us.
Together, we can build a future where prevention, treatment and recovery are accessible to every Australian.”
Stroke Foundation/LinkedIn
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?
-
Sep 3, 2026, 10:42Jared Griffard: Hemorrhagic Shock and Component Blood Transfusion
-
Sep 3, 2026, 10:31Alan Nurden: Comparing Antiplatelet and Antithrombin Therapies in Coronary Microcirculation
-
Sep 3, 2026, 08:53Jamie’s Journey Through a Decade with Immune Thrombocytopenia – ITP Support Association
-
Sep 3, 2026, 08:00Beth Meneley: When Transfusion Is Not an Option – HBOT for Exceptional Blood Loss Anemia
-
Sep 3, 2026, 06:27Seyed Mehrab Safdari: Unmasking Factor VII Padua to Prevent Unnecessary Therapy and Thrombotic Risk
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease